{
    "2021-11-05": [
        [
            {
                "time": "",
                "original_text": "华东医药“夺印”风波后续：与子公司握手言和？医美增收不增利，下一个增长点在哪？",
                "features": {
                    "keywords": [
                        "华东医药",
                        "夺印",
                        "风波",
                        "子公司",
                        "握手言和",
                        "医美",
                        "增收不增利",
                        "增长点"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华东医药、复锐医疗布局，械企押注医美赢面有多大？",
                "features": {
                    "keywords": [
                        "华东医药",
                        "复锐医疗",
                        "布局",
                        "械企",
                        "医美",
                        "赢面"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医美",
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}